Of interest therefore were our findings that LMTK2 levels are reduced in Alzheimer’s disease cortex (affected region) and that this reduction occurs in mid (Braak stage III-IV) as well as severe (Braak stage VI) dementia cases. The gene discussed is LMTK2; the disease is early-onset autosomal dominant Alzheimer disease.